Radiofrequency ablation is effective for the treatment of high-grade dysplasia in Barrett's esophagus after failed photodynamic therapy.

Endoscopic radiofrequency ablation (RFA) is an effective treatment for high-grade dysplasia in Barrett's esophagus in ablation-naïve patients, but no studies have evaluated its use in patients in whom ablative therapy has previously failed. We describe 14 patients with residual high-grade dysplasia following aminolevulinic acid or Photofrin (porfimer sodium) photodynamic therapy (PDT). An overall complete reversal of dysplasia was achieved in 86 % with a combination of RFA and rescue endoscopic mucosal resection. The median total follow-up is 19 months. The rate of strictures was 7 % (1/14) and there was a low rate of buried glands (0.5 % follow-up biopsies). These data suggest RFA is both safe and effective for eradication of high-grade dysplasia in patients in whom PDT has failed.

[1]  J. Dunn1,et al.  Radiofrequency ablation is effective for the treatment of high-grade dysplasia in Barrett’s esophagus after failed photodynamic therapy , 2011 .

[2]  Kenneth K Wang,et al.  92 Durability of Epithelial Reversion After Radiofrequency Ablation: Follow-up of the AIM Dysplasia Trial , 2010 .

[3]  C. Mosse,et al.  Optimal conditions for successful ablation of high-grade dysplasia in Barrett’s oesophagus using aminolaevulinic acid photodynamic therapy , 2009, Lasers in Medical Science.

[4]  Ananya Das,et al.  Circumferential and Focal Ablation of Barrett's Esophagus Containing Dysplasia , 2009, The American Journal of Gastroenterology.

[5]  Kenneth J. Chang,et al.  Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a U.S. Multicenter Registry. , 2008, Gastrointestinal endoscopy.

[6]  P. Fockens,et al.  Stepwise circumferential and focal ablation of Barrett’s esophagus with high-grade dysplasia: results of the first prospective series of 11 patients , 2008, Endoscopy.

[7]  P. Fockens,et al.  Effective treatment of early Barrett’s neoplasia with stepwise circumferential and focal ablation using the HALO system , 2008, Endoscopy.

[8]  B. Overholt,et al.  Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia. , 2007, Gastrointestinal endoscopy.

[9]  Michael Vieth,et al.  The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. , 2006, Gastroenterology.

[10]  Bergein F Overholt,et al.  Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. , 2005, Gastrointestinal endoscopy.

[11]  Carissa A. Sanchez,et al.  Biologic Properties of Columnar Epithelium Underneath Reepithelialized Squamous Mucosa in Barrett's Esophagus , 2005, The American journal of surgical pathology.

[12]  N. Vakil,et al.  Barrett's esophagus and argon plasma coagulation: buried trouble? , 2003, American Journal of Gastroenterology.

[13]  I. Salmon,et al.  Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett's oesophagus , 2000, Gut.

[14]  B. Overholt,et al.  Squamous overgrowth is not a safety concern for photodynamic therapy for Barrett's esophagus with high-grade dysplasia. , 2009, Gastroenterology.

[15]  R. Pearson.  Radiofrequency Ablation in Barrett's Esophagus with Dysplasia , 2009 .